Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast and allopurinol in moderate to severe gout
NCT01109121Phase 2Completed
- Sponsor
- Nuon Therapeutics, Inc.
- Start
- Jun 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranilast in gout, hyperuricemia, sponsored by Nuon Therapeutics, Inc.. Started Jun 2010; status: completed.
02
Drugs
tranilast
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT01109121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109121.